LivaNova · 10 hours ago
Customer Service Analyst
LivaNova is a global medtech company dedicated to changing the trajectory of lives through innovative healthcare solutions. The Customer Service Analyst position involves providing administrative assistance and support to management staff, performing a variety of office functions, and ensuring efficient departmental operations.
Health CareMedical DeviceNeuroscience
Responsibilities
Provide direct administrative assistance
Performs general office functions to include but not limited to arranging meetings and conference calls, travel coordination, typing correspondence, filing, copying, faxing, and preparation of mailing documents and packages
Assist with processing faxes, IWRFs, MDFs/PIQs, BRCs
Assist/Process incoming and outgoing mail (EOS/NoBLE Letters to MD/Patients)
Answering first-line CM Departmental calls/emails
Answers questions relating to office or departmental operations and established policies and procedures
Verifying Benefits and updating SFDC
Performs other duties as may be required by the supervisor
Maintain departmental files and documentation as required
Qualification
Required
High school diploma or equivalent; some college preferred
Strong organizational skills with attention to detail
Excellent verbal and written communication skills
Strong work ethics
High level of integrity and tact
Proficiency in Microsoft Word, Excel, and PowerPoint
Ability to work overtime, as required
Company
LivaNova
LivaNova is a medical technology company that specializes in advanced cardiac surgery, neuromodulation, and circulatory support solutions.
H1B Sponsorship
LivaNova has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (15)
2024 (7)
2023 (6)
2022 (7)
2021 (9)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$300M2024-03-05Post Ipo Debt· $300M
2015-10-19IPO
Recent News
2025-12-24
MarketScreener
2025-12-02
Company data provided by crunchbase